All Stories

  1. Identification of meteorological factors associated with human infection with avian influenza A H7N9 virus in Zhejiang Province, China
  2. Targeting Adults for Supplementary Immunization Activities of Measles Control in Central China: A Mathematical Modelling Study
  3. Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China
  4. Incorporating methylation genome information improves prediction accuracy for drug treatment responses
  5. A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes
  6. Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
  7. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
  8. Benefits and limitations of implementing Chronic Care Model (CCM) in primary care programs: A systematic review
  9. Approximate Bayesian algorithm to estimate the basic reproduction number in an influenza pandemic using arrival times of imported cases
  10. An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: A retrospective analysis of patient exposure histories in Zhejiang province, China
  11. Hsc70 regulates the IRES activity and serves as an antiviral target of enterovirus A71 infection
  12. Estimation of clinical parameters of chronic kidney disease by exhaled breath full-scan mass spectrometry data and iterative PCA with intensity screening algorithm
  13. Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
  14. Short Sleep Duration Increases Metabolic Impact in Healthy Adults: A Population-Based Cohort Study
  15. Abstract LB-254: Thymidylate synthase gene polymorphisms is negatively associated with gastric cancer survival
  16. Stratified polygenic risk prediction model with application to CAGI bipolar disorder sequencing data
  17. Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adults
  18. Age, gender, and socioeconomic gradients in metabolic syndrome: biomarker evidence from a large sample in Taiwan, 2005–2013
  19. Prediction Factors of Recurrent Stroke among Chinese Adults Using Retinal Vasculature Characteristics
  20. A Zoom-Focus algorithm (ZFA) to locate the optimal testing region for rare variant association tests
  21. A statistical method utilizing information of imported cases to estimate the transmissibility for an influenza pandemic
  22. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China
  23. Airway disease and environmental aeroallergens in eczematics approaching adulthood
  24. Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
  25. Epidemiological study of hypertensive retinopathy in the primary care setting: Retrospective cross-sectional review of retinal photographs
  26. Clinically important difference of Stroke-Specific Quality of Life Scale for aneurysmal subarachnoid hemorrhage
  27. A clustering approach to identify rare variants associated with hypertension
  28. Use of a least absolute shrinkage and selection operator (LASSO) model to selected ion flow tube mass spectrometry (SIFT-MS) analysis of exhaled breath to predict the efficacy of dialysis: a pilot study
  29. A fast and powerful W-test for pairwise epistasis testing
  30. A W-test collapsing method for rare-variant association testing in exome sequencing data
  31. Prospective Association between Diabetic Retinopathy and Cardiovascular Disease—A Systematic Review and Meta-analysis of Cohort Studies
  32. Electroacupuncture and splinting versus splinting alone to treat carpal tunnel syndrome: a randomized controlled trial
  33. Genetic evolution of Human Enterovirus A71 subgenotype C4 in Shenzhen, China, 1998–2013
  34. A fast and powerfulW-test for pairwise epistasis testing
  35. Concurrent epidemics of influenza A/H3N2 and A/H1N1pdm in Southern China: A serial cross-sectional study
  36. Retinal Information is Independently Associated with Cardiovascular Disease in Patients with Type 2 diabetes
  37. Interpreting the transmissibility of the avian influenza A(H7N9) infection from 2013 to 2015 in Zhejiang Province, China
  38. The diminishing socioeconomic disparity in obesity in a Chinese population with rapid economic development: analysis of serial cross-sectional health survey data 2002–2010
  39. Cognitive outcome in acute simvastatin treatment for aneurysmal subarachnoid hemorrhage: A propensity matched analysis
  40. Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage
  41. Detection of Nasopharyngeal Carcinoma by MR Imaging: Diagnostic Accuracy of MRI Compared with Endoscopy and Endoscopic Biopsy Based on Long-Term Follow-Up
  42. Mixed response and time-to-event endpoints for multistage single-arm phase II design
  43. Patient Flow Evaluation with System Dynamic Model in an Emergency Department: Data Analytics on Daily Hospital Records
  44. Risk-Adjusted Monitoring Method for Surgical Data: Methodology for Data Analytics (Work in Progress)
  45. Two Screening Methods for Genetic Association Study with Application to Psoriasis Microarray Data Sets
  46. Identifying Meteorological Drivers for the Seasonal Variations of Influenza Infections in a Subtropical City — Hong Kong
  47. High-Dose Simvastatin for Aneurysmal Subarachnoid Hemorrhage
  48. Four pairs of gene–gene interactions associated with increased risk for type 2 diabetes (CDKN2BAS–KCNJ11), obesity (SLC2A9–IGF2BP2, FTO–APOA5), and hypertension (MC4R–IGF2BP2) in Chinese women
  49. Interleukin-27 Is Differentially Associated with HIV Viral Load and CD4+ T Cell Counts in Therapy-Naïve HIV-Mono-Infected and HIV/HCV-Co-Infected Chinese
  50. Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
  51. Changes in pulmonary tuberculosis prevalence: evidence from the 2010 population survey in a populous province of China
  52. Risk factors and natural history of breast cancer in younger Chinese women
  53. Detection of Neovascularization Based on Fractal and Texture Analysis with Interaction Effects in Diabetic Retinopathy
  54. Estimating the incidence reporting rates of new influenza pandemics at an early stage using travel data from the source country
  55. Cross Sectional Survey of Influenza Antibodies before and during the 2009 Pandemic in Shenzhen, China
  56. Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang
  57. Modeling the impact of air, sea, and land travel restrictions supplemented by other interventions on the emergence of a new influenza pandemic virus
  58. Ultra-Early (within 24 Hours) Aneurysm Treatment After Subarachnoid Hemorrhage
  59. Health-Related Quality of Life After Aneurysmal Subarachnoid Hemorrhage
  60. Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
  61. Primary Nasopharyngeal Carcinoma: Diagnostic Accuracy of MR Imaging versus that of Endoscopy and Endoscopic Biopsy
  62. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis
  63. Association of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populations
  64. Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast
  65. Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural ne...
  66. Respone to Letter by Keller and Muroi
  67. Plasma Magnesium Concentrations and Clinical Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients: Post Hoc Analysis of Intravenous Magnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage Trial
  68. Intravenous Magnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage (IMASH): A Randomized, Double-Blinded, Placebo-Controlled, Multicenter Phase III Trial
  69. Human Papillomavirus DNA Detection in Menstrual Blood from Patients with Cervical Intraepithelial Neoplasia and Condyloma Acuminatum
  70. Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability
  71. Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms
  72. Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
  73. The application of wavelet-based neural network on DNA microarray data
  74. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma
  75. Factors related to sexual health in Chinese women with breast cancer in Hong Kong
  76. The impact of 18 F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
  77. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
  78. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control
  79. Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease
  80. Curcumin effects on blood lipid profile in a 6-month human study
  81. Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
  82. A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
  83. Nasopharyngeal Cancers: Which Method Should be Used to Measure these Irregularly Shaped Tumors on Cross-Sectional Imaging?
  84. A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy
  85. Digital PCR for the molecular detection of fetal chromosomal aneuploidy
  86. Impact of SARS on development of childhood acute lymphoblastic leukaemia
  87. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women
  88. Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma
  89. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma
  90. Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization
  91. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity
  92. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial
  93. Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
  94. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
  95. Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)
  96. Planned Equivalence or Noninferiority Trials Versus Unplanned Noninferiority Claims: Are They Equal?
  97. A Comparison of Wound Treatments in Nasopharyngeal Cancer Patients Receiving Radiation Therapy
  98. An Intensive Surveillance Program Detected a High Incidence of Hepatocellular Carcinoma Among Hepatitis B Virus Carriers With Abnormal Alpha-Fetoprotein Levels or Abdominal Ultrasonography Results
  99. A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon  -2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
  100. Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer
  101. Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
  102. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
  103. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience
  104. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group
  105. Knowledge, Perceptions, and Attitudes of Hong Kong Chinese Women on Screening Mammography and Early Breast Cancer Management
  106. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group
  107. Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes
  108. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience
  109. Quality of Life in Ovarian Cancer Patients: Comparison of Paclitaxel Plus Cisplatin, With Cyclophosphamide Plus Cisplatin in a Randomized Study
  110. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18
  111. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
  112. Methodology for quality-of-life assessment: a critical appraisal
  113. Association of Human‐Leukocyte‐Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome
  114. Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA
  115. Determining the Relationship Between Toxicity and Quality of Life in an Ovarian Cancer Chemotherapy Clinical Trial
  116. Staging of Nasopharyngeal Carcinoma: Suggestions for Improving the Current UICC/AJCC Staging System11Presented in part at the 4th International UICC Symposium on Nasopharyngeal Carcinoma, Hong Kong, February 2003.
  117. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
  118. Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy
  119. Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein-Barr Virus DNA and Anti-Epstein-Barr Viral Capsid Antigen IgA Antibody
  120. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy
  121. Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group
  122. Prospective validation of serum CYFRA 21-1, ?-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy
  123. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
  124. A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma
  125. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma?a prospective study
  126. Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
  127. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type
  128. A comparison of the incidence, duration, and degree of the neurologic toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC)
  129. Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?
  130. Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma
  131. Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European O...
  132. Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma
  133. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
  134. Quantitative measurement of post-irradiation neck fibrosis based on the young modulus
  135. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
  136. Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
  137. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system
  138. Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group
  139. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy
  140. Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group
  141. Application of Classification Tree and Neural Network Algorithms to the Identification of Serological Liver Marker Profiles for the Diagnosis of Hepatocellular Carcinoma
  142. Three-dimensional metacarpophalangeal joint kinematics using two markers on the phalanx
  143. Improved local control for early T-stage nasopharyngeal carcinoma – a tale of two hospitals
  144. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma
  145. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma
  146. Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  147. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
  148. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose–tumor-control relationship above conventional tumoricidal dose
  149. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
  150. Gait assessment in unicompartmental knee arthroplasty patients: Principal component modelling of gait waveforms and clinical status
  151. Virulizin® - a review of its antineoplastic activity
  152. MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
  153. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer
  154. Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study
  155. Trauma Patients with Multiple Extremity Injuries
  156. Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group
  157. Growth curve model analysis for quality of life data
  158. Mammographic density in women on postmenopausal hormone replacement therapy
  159. Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30
  160. Effect of postchemotherapy nausea and vomiting on health-related quality of life
  161. Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival
  162. Validation of a 3D optoelectronic motion analysis system for the wrist joint
  163. Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity
  164. Vascularity demonstrated by doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast
  165. Thermography: Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast
  166. A proposal for a new approach to intergroup cancer trials
  167. Changes in mean trabecular orientation in the medial condyle of the proximal tibia in osteoarthritis
  168. Trabecular microstructure in the medial condyle of the proximal tibia of patients with knee osteoarthritis
  169. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer
  170. Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting
  171. Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer
  172. Assessing the Reliability of Two Toxicity Scales: Implications for Interpreting Toxicity Data
  173. Immunohistochemical Characteristics of Human Milk-fat Globule Antibodies in Predicting Chest Wall and Distant Metastasis After Mastectomy for Localized Cancer of the Breast
  174. Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer
  175. Immunohistochemical reaction to human milk fat globule antibodies and breast cancer differentiation
  176. Thermography as a predictor of prognosis in cancer of the breast
  177. Trimetrexate: Predictors of Severe or Life-Threatening Toxic Effects
  178. Renal vascular histology and morphometry in systemic sclerosis. a case–control autopsy study
  179. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide